SGBV · ALG Health Care BIO
Biopharm share price
BIO · Biopharm
DZD 1,250.00 ▼ DZD 6.38 · -0.51%
Market closed · 10:15 local Jun 26, 2026 Prices delayed ≥15 min Sample data
Price chart
…
Key statistics
Market cap
DZD 47.50B
P/E (TTM)
12.0×
EPS (TTM)
DZD 104.17
Dividend yield
3.17%
52-week range
DZD 861.14 – DZD 1,343.07
Avg volume
105.3K
Beta
1.14
Prev close
DZD 1,256.38
About Biopharm
AI-assisted summaryBiopharm (BIO) is a company listed on SGBV in the Health Care sector. This page summarises its share price, key statistics, dividends and fundamentals using delayed and sample data — figures may differ from official sources.
Dividend history
Annual payout (TTM): DZD 39.63 · Forward yield: 3.17%| Ex-date | Pay date | Amount | Frequency | Dividend yield |
|---|---|---|---|---|
| Jun 21, 2026 | Jun 28, 2026 | DZD 39.63 | Annual | 3.17% |
| Jun 21, 2025 | Jun 28, 2025 | DZD 37.86 | Annual | 3.03% |
| Jun 21, 2024 | Jun 28, 2024 | DZD 36.99 | Annual | 2.96% |
Financials
Annual figures, last 5 fiscal years.
| Date | Revenue | Net income | EPS (TTM) | P/E (TTM) |
|---|---|---|---|---|
| FY2024 | DZD 34.32B | DZD 6.16B | DZD 76.27 | 13.5× |
| FY2023 | DZD 30.64B | DZD 2.74B | DZD 83.13 | 13.1× |
| FY2022 | DZD 25.89B | DZD 2.30B | DZD 93.26 | 12.4× |
| FY2021 | DZD 22.21B | DZD 2.28B | DZD 103.01 | 11.9× |
| FY2020 | DZD 18.84B | DZD 2.42B | DZD 107.35 | 10.3× |
Stock splits
No stock splits on record for Biopharm.
Analyst forecast
12-month price target
DZD 1,165.20
Consensus rating
Sell
Implied upside
-6.78%
Based on 25 analysts
12-month
Aggregated analyst estimates (sample)
Related
Frequently asked questions
What is the current Biopharm share price?
Biopharm (BIO) last traded at DZD 1,250.00, as of Jun 26, 2026. Prices on bourva are delayed and shown for reference only.
Does Biopharm pay a dividend?
Yes — Biopharm has a forward dividend yield of about 3.17%, based on its trailing 12-month payout.
What is Biopharm's market capitalisation?
Biopharm has an approximate market capitalisation of DZD 47.50B.
What is Biopharm's P/E ratio?
Biopharm trades at a trailing P/E ratio of about 12.0.